XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Product revenue $ 3,139 $ 597
Other revenue 0 0
Total revenues 3,139 597
Cost of goods sold (903) (181)
Gross profit 2,236 416
Operating expenses:    
Research and development expenses 3,700 4,576
Selling, general and administrative expenses 8,814 4,165
Total operating expenses 12,514 8,741
Operating loss (10,278) (8,325)
Change in fair value of warrant liability (612) 0
Interest expense, net (199) (688)
Other (expense) income (22) 13
Net loss (11,111) (9,000)
Other comprehensive (loss) income:    
Unrealized gain on investments 8 0
Foreign currency translation adjustments 14 19
Total comprehensive loss $ (11,089) $ (8,981)
Common share data:    
Basic loss per common share (in dollars per share) $ (0.45) $ (0.77)
Diluted loss per common share (in dollars per share) $ (0.45) $ (0.77)
Weighted average number of basic shares outstanding (in shares) 24,887,180 11,622,384
Weighted average number of diluted shares outstanding (in shares) 24,887,180 11,622,384